🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 30% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 mL Serving Size
60 Servings
Other Combinations Product Type
30% Evidence Coverage

Supplement Facts — Evidence Check

Calories
9 {Calories}
Total Fat
0.9 Not Present (1.5% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 118.3mg UL 3000mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 155mg UL 3000mg
Alpha-Linolenic Acid
62.5 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 335mg UL 3000mg
Gamma-Linolenic Acid
6 mg
Linoleic Acid
20.3 mg
Oleic Acid
5.4 mg
Other Fatty Acids

Other Ingredients

Tropical Oils Natural Flavors Tocopherol Rosemary extract

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Children 4 or More Years of Age Sugar Free Children more than 1 but less than 4

Product Information

📋 Directions for Use

DIRECTIONS FOR USE: Shake well before use. Children under 2 consult physician. Children 2-4 take 1 mL daily. Children 4 yrs and over take 2 mL once daily. (30 day supply)

🧪 Formulation Notes

No sugar, alcohol, artificial color, artificial flavor.

Essential Omega Fatty Acids DHA, EPA (3, 6, 9)

Additional Information

Super Concentrate Ultra pure Brainy Play fatty essential fatty acids (Omega 3, 6, 9) promotes healthy heart, brain, and nervous system development in children.

KEEP REFRIGERATED

MADE IN U.S.A.

#510 I/8

Product Details

UPC / SKU 635585051018
DSLD Entry Date 2013-06-25
Product Type Other Combinations
Form Liquid
Brand KidzPlay
DSLD ID 22250
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →